drugset / Trial / NCT04158076
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine in patients with primary hypercholesterolemia and essential hypertension.
Timeline
- Start
- 2020-01-23
- Primary completion
- 2021-01-14
- Completion
- 2021-01-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ezetimibe/Rosuvastatin | Unknown | — | Oral |
| Comparator | Telmisartan | Other / unclassified | — | Oral |
| Subject | Telmisartan/Amlodipine | Unknown | 5 mg | Oral |
| Subject | Telmisartan/Amlodipine | Unknown | 80 mg | Oral |